We took KRAS mutation detection in PC patients as an example, and tested whether the potential factors during exosome isolation and exosomal DNA preparation, the selection of blood sample type (plasma or serum), as well as the details in mutation analysis by droplet digital PCR (ddPCR), etc., could influence the mutation detection on exosomal DNA. This evidence concerns the gene KRAS and pachyonychia congenita.